Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Ferrarini

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Haematology|March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocolFortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
Frontiers in Oncology|September 18, 2023
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapyFortunato Morabito, Carlo Adornetto, Paola Monti, et al.
Cell Reports|March 17, 2021
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patientsJennifer C Reid, Diana Golubeva, Allison L Boyd, et al.
Molecular Medicine (Cambridge, Mass.)|July 26, 2011
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cellsFabio Ghiotto, Paolo Marcatili, Claudya Tenca, et al.
Journal of Cellular Physiology|December 21, 2012
miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone diseaseMarco Rossi, Maria Rita Pitari, Nicola Amodio, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Haematologica|February 25, 2014
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophagesPaolo Giannoni, Gabriella Pietra, Giorgia Travaini, et al.
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Blood|September 25, 2003
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutationsRajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, et al.
British Journal of Haematology|December 10, 2009
Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLLFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocolFortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
Frontiers in Oncology|September 18, 2023
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapyFortunato Morabito, Carlo Adornetto, Paola Monti, et al.
Cell Reports|March 17, 2021
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patientsJennifer C Reid, Diana Golubeva, Allison L Boyd, et al.
Molecular Medicine (Cambridge, Mass.)|July 26, 2011
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cellsFabio Ghiotto, Paolo Marcatili, Claudya Tenca, et al.
Journal of Cellular Physiology|December 21, 2012
miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone diseaseMarco Rossi, Maria Rita Pitari, Nicola Amodio, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Haematologica|February 25, 2014
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophagesPaolo Giannoni, Gabriella Pietra, Giorgia Travaini, et al.
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Blood|September 25, 2003
Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutationsRajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, et al.
British Journal of Haematology|December 10, 2009
Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLLFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Pageof 13